𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genotype–phenotype correlation in von Hippel-Lindau families with renal lesions

✍ Scribed by Catherine Gallou; Dominique Chauveau; Stéphane Richard; Dominique Joly; Sophie Giraud; Sylviane Olschwang; Natacha Martin; Céline Saquet; Yves Chrétien; Arnaud Méjean; Jean-Michel Correas; Gérard Benoît; Pierre Colombeau; Jean-Pierre Grünfeld; Claudine Junien; Christophe Béroud


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
282 KB
Volume
24
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


von Hippel-Lindau (VHL) disease arises from mutations in the VHL gene and predisposes patients to develop a variety of tumors in different organs. In the kidney, single or multiple cysts and renal cell carcinomas (RCC) may occur. Both inter- and intrafamilial heterogeneity in clinical expression are well recognized. To identify VHL-dependent genetic factors, we investigated the renal phenotype in 274 individuals from 126 unrelated VHL families in whom 92 different VHL mutations were characterized. The incidence of renal involvement was increased in families with mutations leading to truncated protein (MLTP) or large rearrangement, as compared to families with missense changes (81 vs. 63%, respectively; P=0.03). In the latter group, we identified two mutation cluster regions (MCRs) associated with a high risk of harboring renal lesions: MCR-1 (codons 74-90) and MCR-2 (codons 130-136). In addition, the incidence of RCC was higher in families with MLTP than in families with missense changes (75 vs. 57%; P=0.04). Furthermore, mutations within MCR-1 but not MCR-2 conferred genetic susceptibility to develop RCC. Overall, our data argued for a substantial contribution of the genetic change in the VHL gene to susceptibility to renal phenotype in VHL patients.


📜 SIMILAR VOLUMES


Genotype–phenotype correlations in von H
✍ Kai Ren Ong; Emma R. Woodward; Pip Killick; Caron Lim; Fiona Macdonald; Eamonn R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Communicated by David N. Cooper von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome resulting from mutations in the VHL tumor suppressor gene. VHL disease displays marked variation in expression and the presence of pheochromocytoma has been linked to missense VHL mutat

Genotype–phenotype correlations of pheoc
✍ Sarah M. Nielsen; Wendy S. Rubinstein; Darcy L. Thull; Michaele J. Armstrong; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract Von Hippel–Lindau (VHL) disease type 2A is an inherited tumor syndrome characterized by predisposition to pheochromocytoma (pheo), retinal hemangioma (RA), and central nervous system hemangioblastoma (HB). Specific VHL subtypes display genotype–phenotype correlations but, unlike other f

Mutation screening and genotype-phenotyp
✍ Muriel Bost; Alain Lachaux; Michèle Accominotti; Antoon Vandenberghe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

Wilson disease (WD) is an autosomal recessive disorder of copper transport, manifesting as chronic liver disease and/or neurologic impairment due to accumulation of copper in several tissues, principally the liver and the brain. The WD gene encodes a copper transporting P-type ATPase that is defecti

Vascular endothelial growth factor overe
✍ Hiroshi Igarashi; Mariko Esumi; Hajime Ishida; Kiyoki Okada 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND A high frequency of genetic alterations of the von Hippel‐Lindau (__VHL)__ gene and overexpression of the vascular endothelial growth factor (__VEGF)__ gene have been observed independently in human sporadic renal cell carcinoma (RCCs), but to the authors' knowledge the a

Somatic von Hippel–Lindau disease gene m
✍ Minoru Yoshida; Masahiro Yao; Isao Ishikawa; Takeshi Kishida; Yoji Nagashima; Ke 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

## Abstract It has been documented that renal cell carcinomas (RCCs) occur frequently in patients treated with long‐term dialysis, especially in cases of end‐stage renal disease (ESRD)/acquired cystic disease of the kidney (ACDK). To address the molecular pathogenesis of ESRD/ACDK‐associated RCCs,